Skip to main content
Clinical Trials/NCT00527293
NCT00527293
Completed
Early Phase 1

Partial Breast Irradiation for Patients Undergoing Breast Conservation Therapy for Early Stage Breast Cancer: A Pilot Study

Case Comprehensive Cancer Center4 sites in 1 country29 target enrollmentJune 2007
ConditionsBreast Cancer

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Case Comprehensive Cancer Center
Enrollment
29
Locations
4
Primary Endpoint
Determination of which patients are best suited for each individual technique of partial breast irradiation
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells.

PURPOSE: This clinical trial is studying how well partial breast radiation therapy works in treating women undergoing breast-conserving therapy for early stage breast cancer.

Detailed Description

OBJECTIVES: * To determine the cosmetic outcome resulting from partial breast irradiation using two different techniques. * To determine patient satisfaction with partial breast irradiation as it pertains to their overall treatment experience as measured by a questionnaire. * To determine if there are patient factors that limit a patient's suitability to receive partial breast irradiation delivered by a particular technique. * To evaluate wound healing and overall complication rate after partial breast irradiation. * To determine ipsilateral breast tumor recurrence rates and tumor bed recurrence rates. OUTLINE: Patients undergo partial breast irradiation comprising either MammoSite® brachytherapy twice daily for 5-10 days OR 3-dimensional conformal radiotherapy twice daily for 5-10 days. After completion of study therapy, patients are followed periodically for up to 5 years.

Registry
clinicaltrials.gov
Start Date
June 2007
End Date
February 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Determination of which patients are best suited for each individual technique of partial breast irradiation

Time Frame: Patients will be followed for a period of five years following completion of radiation.

Ipsilateral breast tumor recurrence rates and tumor bed recurrence rates

Time Frame: Ipsilateral breast 6 mos after dx, bilateral annually x 5 years

Wound healing and overall complication rate after partial breast irradiation

Time Frame: 1 month after RT & Q3mos for one year

Cosmetic outcome as determined by an established scale employed by the radiation oncologist and the surgeon

Time Frame: 1 month after RT & Q3mos for one year

Patient satisfaction with partial breast irradiation as measured by a questionnaire

Time Frame: Pre-treatment 1 mo 3 mo 6 mo 9 mo 1yr 5 yr

Study Sites (4)

Loading locations...

Similar Trials